MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

385.12 +3.25 (+0.85%)
Streaming Delayed Price Updated: 3:37 PM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,222,138
Open 381.91
Bid (Size) 384.97 (3)
Ask (Size) 385.27 (1)
Prev. Close 381.87
Today's Range 379.72 - 387.48
52wk Range 362.50 - 519.88
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pharma Tariffs Back In Spotlight On New Trump Threat
President Donald Trump threatened 100% tariffs on some drug imports. 
Via Investor's Business Daily
Topics ETFs Government World Trade
Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet
Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-de 
Via Benzinga
Topics Government World Trade

Performance

YTD
-5.1%
-5.1%
1 Month
-0.5%
-0.5%
3 Month
-13.1%
-13.1%
6 Month
-23.4%
-23.4%
1 Year
-16.6%
-16.6%

More News

Read More
CrowdStrike To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Assessing Vertex Pharmaceuticals: Insights From 15 Financial Analysts
Via Benzinga
Vertex Announces Key Advancements Across Kidney Portfolio
From Vertex Pharmaceuticals Incorporated
Via Business Wire
This Chewy Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Via Benzinga
My 3 Favorite Stocks to Buy Right Now
Via The Motley Fool
Topics Artificial Intelligence Economy
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Top GARP Stock
Via Chartmill
Vertex Partners with Basketball World Champion Jayson Tatum to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe-Acute Pain
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Unpacking Q2 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
Healthcare Stocks Are at an Historic Low and a Turnaround Is on the Horizon
Via The Motley Fool
Topics Government Intellectual Property World Trade
My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years
Via Benzinga
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy
From Vertex Pharmaceuticals
Via Business Wire
2 Growth Stocks to Buy and Hold Forever
Via The Motley Fool
Topics World Trade
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Screens as a Top Undervalued Stock with Strong Fundamentals
Via Chartmill
Why This Biotech Company Could Be a Growth Stock Powerhouse
Via The Motley Fool
1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals
Via The Motley Fool
Topics Intellectual Property
3 Absurdly Cheap Stocks to Buy for the Long Haul
Via The Motley Fool
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 15 Years
Via Benzinga
Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Fundamentals and Technical Breakout Potential
Via Chartmill
Cathie Wood Goes Bargain Hunting: She Just Bought 2 Stocks That Wall Street Thinks Will Climb 50% and 190%
Via The Motley Fool
1 Safe-and-Steady Stock to Research Further and 2 We Turn Down
Via StockStory
Why This Biotech Company Could Be a Growth Stock Powerhouse
Via The Motley Fool
Demystifying Vertex Pharmaceuticals: Insights From 16 Analyst Reviews
Via Benzinga

Frequently Asked Questions

Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 385.12
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 09/26/25 03:37 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 99.91B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 100B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
TOP
Email a Story